Sera Prognostics, Inc.

SERA ·Healthcare, Medical Care Facilities, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Operating Activities
Net Income $-31.9M $-32.9M $-36.2M $-44.2M $-35.0M $-19.8M
Depreciation & Amortization $940.0K $833.0K $900.0K $756.0K $659.0K $895.0K
Depreciation $800.0K $800.0K — — — —
Amortization $116.0K $19.0K — — — —
Stock-Based Compensation $5.1M $7.0M $5.3M $5.1M $3.1M $726.0K
Net Cash from Operating Activities $-25.6M $-14.2M $-27.2M $-34.6M $-31.6M $-16.9M
Investing Activities
Capital Expenditures $726.0K $56.0K $128.0K $791.0K $1.3M $149.0K
Business Acquisitions — — — — — —
Net Cash from Investing Activities $-28.5M $11.7M $438.0K $5.6M $-82.6M $-149.0K
Financing Activities
Dividends Paid — — — — — —
Stock Repurchases — — — — — —
Net Cash from Financing Activities $54.0M $2.6M $752.0K $5.0K $159.6M $9.2M
Net Change in Cash — — — — — —
Free Cash Flow $-26.3M $-14.2M $-27.3M $-35.4M $-32.9M $-17.0M